High-performance experts.

When it’s all on the line.

Article

Financial Regulations in Football: Caught Offside?

This article discusses the application of the current financial regulations (including PSR) to PL clubs and recent trends in compliance with these regulations, and examines certain aspects of the current regulations that the regulators could look to improve upon to deal with issues that arise from creative accounting practices and misaligned incentives.

Article

Challenges to Quantifying Economic Harm from Data Breaches

Quantifying economic harm resulting from data breaches is challenging. It requires sound economic analysis to address a range of issues, including issues related to personal data exposure and the valuation of privacy, the use of dark-web data for benchmarking, and the difficulties in assessing mitigation costs for class-action lawsuits.

Who We Are

Insightful Experts.
Globally Connected.

When the stakes are high, our globally integrated expert teams thrive on working through the most daunting problems in ways that remove uncertainty and instill confidence.

Intellectually Curious.
Relentlessly People-Centric.

We are very selective in whom we choose to join our team. Then again, you wouldn’t want it any other way.

Secretariat by the Numbers

550+

Experts and Advisors Around the World

90%

Engaged by the Top 100 Global Law Firms

6000+

Engagements Completed on 6 Continents

1st

Ranked in GAR 100 Expert Witness Firms’ Power Index 2024

Featured service

International Arbitration

Ranked #1 in Global Arbitration Review’s 2024 Expert Witness Firms’ Power Index, Secretariat’s experts have extensive knowledge of the key issues important to government agencies, arbitration panels, regulators, legal counsel, and business leaders.

Latest Insights

featured Engagements

Biopharmaceutical Reasonable Royalties on Trial

When our client, a biopharmaceutical company, had exclusively licensed a patent for a novel type of cancer immunotherapy, a competitor undertook substantial efforts to be first to market for its lead indication despite being aware of potential infringement claims against its therapy. Upon the competitor achieving FDA approval, our client filed patent infringement claims. After an eight-day trial, the jury returned a verdict in favor of our client with a damages award that precisely matched the trial testimony.

Become One of the Experts

Join the team of high-performing experts clients call when they are facing their greatest challenges and opportunities.

Talk to Our Insightful Experts